LLY Financial Facts
Research and development: 1.24BCost of sales: 1.4B
See Full Income Statement
Noncontrolling interests: 26.6M
Sundry: 2.28B
See Full Balance Sheet
Eli Lilly (LLY) Earnings
|
Expand Research on LLY
| Next EPS Date | 4/30/24 | EPS Growth Rate | +51.9% |
|---|---|---|---|
| Average EPS % Beat Rate | +40.1% | Revenue Growth Rate | +28.2% |
| Average % Move 1-Wk after EPS | +12.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
1/27/11  |
 |
Q410 | $1.11 | $1.09 | +$0.02 | $6.19B | $5.99B | = |  | | Details |
| 10/21/10 |
|
Q310 | $1.21 | $1.15 | +$0.06 | N/A | N/A | N/A | | | Details |
| 8/8/23 | Q223 | $2.11 | $1.98 | +$0.13 | $8.31B | $7.58B |  |
| | Details | |
| 4/27/23 | Q123 | $1.62 | $1.69 | -$0.07 | $6.96B | $6.84B | |
| | Details | |
| 11/2/23 | Q323 | $0.10 | -$0.20 | +$0.30 | $9.5B | $8.97B | |
| | Details | |
| 7/24/18 | |
Q218 | $1.50 | $1.30 | +$0.20 | $6.36B | $6.05B |  |
| | Details |
| 8/3/21 | |
Q221 | $1.87 | $1.92 | -$0.05 | $6.74B | $6.65B | = | | | Details |
| 10/22/15 |
|
Q315 | $0.89 | $0.75 | +$0.14 | $4.96B | $4.99B | |
| | Details |
